Literature DB >> 22382683

The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases.

Je-Min Choi1, Alfred L M Bothwell.   

Abstract

Members of the nuclear receptor superfamily function as transcription factors involved in innate and adaptive immunity as well as lipid metabolism. These highly conserved proteins participate in ligand-dependent or -independent regulatory mechanisms that affect gene expression. Peroxisome proliferator-activated receptors (PPARs), which include PPARα, PPARβ/δ, and PPARΓ, are a group of nuclear receptor proteins that play diverse roles in cellular differentiation, development, and metabolism. Each PPAR subfamily is activated by different endogenous and synthetic ligands. Recent studies using specific ligand treatments and cell type-specific PPAR knockout mice have revealed important roles for these proteins in T-cell-related autoimmune diseases. Moreover, PPARs have been shown to regulate T-cell survival, activation, and CD4(+) T helper cell differentiation into the Th1, Th2, Th17, and Treg lineages. Here, we review the studies that provide insight into the important regulatory roles of PPARs in T-cell activation, survival, proliferation, differentiation, and autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22382683      PMCID: PMC3887706          DOI: 10.1007/s10059-012-2297-y

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  69 in total

1.  Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent.

Authors:  Dallas C Jones; Xiaohong Ding; Raymond A Daynes
Journal:  J Biol Chem       Date:  2001-11-28       Impact factor: 5.157

2.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Authors:  J P Renaud; N Rochel; M Ruff; V Vivat; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

3.  Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1.

Authors:  P Delerive; K De Bosscher; S Besnard; W Vanden Berghe; J M Peters; F J Gonzalez; J C Fruchart; A Tedgui; G Haegeman; B Staels
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

4.  Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis.

Authors:  K Setoguchi; Y Misaki; Y Terauchi; T Yamauchi; K Kawahata; T Kadowaki; K Yamamoto
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 5.  Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.

Authors:  Philippe Gervois; Jean-Charles Fruchart; Bart Staels
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-02

Review 6.  Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma.

Authors:  Andrzej Zieleniak; Marzena Wójcik; Lucyna A Woźniak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008 Sep-Oct       Impact factor: 4.291

Review 7.  Emerging roles of PPARs in inflammation and immunity.

Authors:  Raymond A Daynes; Dallas C Jones
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

8.  Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis.

Authors:  Paul E Polak; Sergey Kalinin; Cinzia Dello Russo; Vitaliy Gavrilyuk; Anthony Sharp; Jeffrey M Peters; Jill Richardson; Tim M Willson; Guy Weinberg; Douglas L Feinstein
Journal:  J Neuroimmunol       Date:  2005-08-10       Impact factor: 3.221

9.  Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.

Authors:  Maura Agostini; Erik Schoenmakers; Catherine Mitchell; Istvan Szatmari; David Savage; Aaron Smith; Odelia Rajanayagam; Robert Semple; Jian'an Luan; Louise Bath; Anthony Zalin; Mourad Labib; Sudhesh Kumar; Helen Simpson; Dirk Blom; David Marais; John Schwabe; Inês Barroso; Richard Trembath; Nicholas Wareham; Laszlo Nagy; Mark Gurnell; Stephen O'Rahilly; Krishna Chatterjee
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

10.  PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells.

Authors:  Istvan Szatmari; Attila Pap; Ralph Rühl; Jiang-Xing Ma; Petr A Illarionov; Gurdyal S Besra; Eva Rajnavolgyi; Balazs Dezso; Laszlo Nagy
Journal:  J Exp Med       Date:  2006-09-18       Impact factor: 14.307

View more
  64 in total

1.  Protective effects of pioglitazone against immunoglobulin deposition on heart of streptozotocin-induced diabetic rats.

Authors:  M Yuan; M Qiu; J Cui; X Zhang; P Zhang
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

2.  Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.

Authors:  Patricia K A Mongini; Jill M Kramer; Tomo-O Ishikawa; Harvey Herschman; Donna Esposito
Journal:  Clin Immunol       Date:  2014-03-29       Impact factor: 3.969

3.  Advanced inhibition of undesired human hair growth by PPARγ modulation?

Authors:  Yuval Ramot; Arianna Mastrofrancesco; Erika Herczeg-Lisztes; Tamás Bíró; Mauro Picardo; Jennifer E Kloepper; Ralf Paus
Journal:  J Invest Dermatol       Date:  2013-11-11       Impact factor: 8.551

Review 4.  Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier.

Authors:  Diane C Lim; Allan I Pack
Journal:  Sleep Med Rev       Date:  2013-03-28       Impact factor: 11.609

Review 5.  Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.

Authors:  Vineet K Dhiman; Michael J Bolt; Kevin P White
Journal:  Nat Rev Genet       Date:  2017-12-27       Impact factor: 53.242

6.  Cholesterol-Independent Suppression of Lymphocyte Activation, Autoimmunity, and Glomerulonephritis by Apolipoprotein A-I in Normocholesterolemic Lupus-Prone Mice.

Authors:  Leland L Black; Roshni Srivastava; Trenton R Schoeb; Ray D Moore; Stephen Barnes; Janusz H Kabarowski
Journal:  J Immunol       Date:  2015-10-14       Impact factor: 5.422

Review 7.  The spectrum of T cell metabolism in health and disease.

Authors:  Glenn R Bantug; Lorenzo Galluzzi; Guido Kroemer; Christoph Hess
Journal:  Nat Rev Immunol       Date:  2017-09-25       Impact factor: 53.106

8.  In vivo activation of invariant natural killer T cells induces systemic and local alterations in T-cell subsets prior to preterm birth.

Authors:  N Gomez-Lopez; R Romero; M Arenas-Hernandez; G Schwenkel; D St Louis; S S Hassan; T N Mial
Journal:  Clin Exp Immunol       Date:  2017-05-10       Impact factor: 4.330

9.  A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D3 Reduces T-Bet Gene Expression, Serum Interferon Gamma, and Clinical Scores but Promotes PPARγ Gene Expression in Experimental Autoimmune Encephalomyelitis.

Authors:  Mohammad Reza Shiri-Shahsavar; Abbas Mirshafiee; Karim Parastouei; Abbas Ebrahimi-Kalan; Saeed Yekaninejad; Farid Soleymani; Reza Chahardoli; Ramin Mazaheri Nezhad Fard; Ali Akbar Saboor-Yaraghi
Journal:  J Mol Neurosci       Date:  2016-09-19       Impact factor: 3.444

10.  Dietary phytol reduces clinical symptoms in experimental autoimmune encephalomyelitis (EAE) at least partially by modulating NOX2 expression.

Authors:  Leonard Blum; Nadja Tafferner; Ilknur Spring; Jennifer Kurz; Natasja deBruin; Gerd Geisslinger; Michael J Parnham; Susanne Schiffmann
Journal:  J Mol Med (Berl)       Date:  2018-08-27       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.